NOVOCURE INC.

Lobbying for NOVOCURE INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $110,000.00 expenses · posted Jul 15, 2025

Bills named in this filing 1

Lobbying activity 2

Medicare/Medicaid

General Medicare Issues. S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.

Veterans

Veterans Affairs / Veterans Health Administration (VHA) issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.